Product NDC: | 44567-240 |
Proprietary Name: | Cefepime |
Non Proprietary Name: | Cefepime |
Active Ingredient(s): | 1 g/20mL & nbsp; Cefepime |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 44567-240 |
Labeler Name: | WG Critical Care, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065441 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130118 |
Package NDC: | 44567-240-10 |
Package Description: | 10 VIAL in 1 CARTON (44567-240-10) > 20 mL in 1 VIAL |
NDC Code | 44567-240-10 |
Proprietary Name | Cefepime |
Package Description | 10 VIAL in 1 CARTON (44567-240-10) > 20 mL in 1 VIAL |
Product NDC | 44567-240 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cefepime |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20130118 |
Marketing Category Name | ANDA |
Labeler Name | WG Critical Care, LLC |
Substance Name | CEFEPIME HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | g/20mL |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |